|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 947.65 INR | -1.45% |
|
+4.18% | -15.14% |
| 14/04 | Cyient Limited's Board intends to launch an Equity Buyback on April 23, 2026 | CI |
| 14/04 | Cyient to consider buyback of equity shares, subject to approvals | RE |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 5.88 | 8.5 | 8.29 | 9.56 | 7.45 | |||||
Return on Total Capital | 7.5 | 10.91 | 11.22 | 12.89 | 9.41 | |||||
Return On Equity % | 13.2 | 17.22 | 15.64 | 17.53 | 12.57 | |||||
Return on Common Equity | 13.19 | 17.2 | 15.63 | 17.68 | 12.87 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 31.83 | 34.32 | 34.71 | 33.91 | 31.16 | |||||
SG&A Margin | 0.67 | 0.6 | 0.39 | 0.49 | 0.44 | |||||
EBITDA Margin % | 12.39 | 16.3 | 14.75 | 16.55 | 12.9 | |||||
EBITA Margin % | 10.43 | 14.53 | 13.42 | 15.55 | 11.93 | |||||
EBIT Margin % | 9.87 | 13.91 | 12.49 | 14.5 | 11.9 | |||||
Income From Continuing Operations Margin % | 8.8 | 11.52 | 8.55 | 9.83 | 8.81 | |||||
Net Income Margin % | 8.8 | 11.52 | 8.55 | 9.55 | 8.36 | |||||
Net Avail. For Common Margin % | 8.8 | 11.52 | 8.55 | 9.55 | 8.36 | |||||
Normalized Net Income Margin | 7.08 | 9.64 | 7.51 | 8.37 | 6.87 | |||||
Levered Free Cash Flow Margin | 13.7 | 8.86 | 7.63 | 0.9 | 7.58 | |||||
Unlevered Free Cash Flow Margin | 14.36 | 9.4 | 8.67 | 1.9 | 8.37 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.95 | 0.98 | 1.06 | 1.05 | 1 | |||||
Fixed Assets Turnover | 5.51 | 6.38 | 8.48 | 9.51 | 9.56 | |||||
Receivables Turnover (Average Receivables) | 3.83 | 4.4 | 4.68 | 4.42 | 4.21 | |||||
Inventory Turnover (Average Inventory) | 14.62 | 13.61 | 11 | 10.46 | 9.7 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.57 | 2.3 | 1.58 | 2.15 | 3.03 | |||||
Quick Ratio | 2.26 | 1.87 | 1.18 | 1.39 | 2.24 | |||||
Operating Cash Flow to Current Liabilities | 0.77 | 0.5 | 0.27 | 0.44 | 0.58 | |||||
Days Sales Outstanding (Average Receivables) | 95.22 | 82.93 | 78 | 82.89 | 86.69 | |||||
Days Outstanding Inventory (Average Inventory) | 24.96 | 26.81 | 33.2 | 35 | 37.61 | |||||
Average Days Payable Outstanding | 54.84 | 57.66 | 55.38 | 53.95 | 31.5 | |||||
Cash Conversion Cycle (Average Days) | 65.34 | 52.08 | 55.82 | 63.94 | 92.8 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 19.55 | 18.61 | 35.26 | 17.76 | 8.94 | |||||
Total Debt / Total Capital | 16.35 | 15.69 | 26.07 | 15.08 | 8.2 | |||||
LT Debt/Equity | 8.16 | 5.73 | 19.92 | 11.53 | 5.3 | |||||
Long-Term Debt / Total Capital | 6.83 | 4.83 | 14.73 | 9.79 | 4.87 | |||||
Total Liabilities / Total Assets | 34.25 | 34.97 | 47.11 | 34.93 | 25.14 | |||||
EBIT / Interest Expense | 9.4 | 16.05 | 7.52 | 9.01 | 9.44 | |||||
EBITDA / Interest Expense | 13.53 | 20.72 | 9.94 | 11.2 | 11.34 | |||||
(EBITDA - Capex) / Interest Expense | 11.26 | 19.07 | 9.27 | 10.45 | 10.22 | |||||
Total Debt / EBITDA | 0.98 | 0.71 | 1.23 | 0.63 | 0.49 | |||||
Net Debt / EBITDA | -1.47 | -0.89 | 0.43 | 0.19 | -0.69 | |||||
Total Debt / (EBITDA - Capex) | 1.18 | 0.77 | 1.32 | 0.67 | 0.54 | |||||
Net Debt / (EBITDA - Capex) | -1.77 | -0.96 | 0.46 | 0.2 | -0.76 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -6.66 | 9.73 | 32.74 | 18.81 | 2.98 | |||||
Gross Profit, 1 Yr. Growth % | -8.06 | 18.32 | 34.26 | 16.18 | -5.36 | |||||
EBITDA, 1 Yr. Growth % | 4.34 | 44.32 | 20.19 | 33.63 | -19.73 | |||||
EBITA, 1 Yr. Growth % | 1.13 | 52.85 | 22.59 | 38.19 | -20.99 | |||||
EBIT, 1 Yr. Growth % | 1.59 | 54.65 | 19.18 | 38.39 | -15.44 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 6.62 | 43.57 | -1.51 | 36.63 | -7.75 | |||||
Net Income, 1 Yr. Growth % | 6.22 | 43.57 | -1.51 | 32.74 | -9.83 | |||||
Normalized Net Income, 1 Yr. Growth % | -1.1 | 48.7 | 3.39 | 32.69 | -15.56 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 6.14 | 43.8 | -1.75 | 32.11 | -10.05 | |||||
Accounts Receivable, 1 Yr. Growth % | -8.8 | 0.33 | 49.18 | 10.3 | 5.92 | |||||
Inventory, 1 Yr. Growth % | -30.04 | 75.91 | 56.2 | 7.3 | 23.31 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -5.38 | -5.11 | 5.16 | 6.47 | -1.36 | |||||
Total Assets, 1 Yr. Growth % | 7.49 | 6.55 | 36.78 | 6.96 | 9.87 | |||||
Tangible Book Value, 1 Yr. Growth % | 19 | 9.48 | -45.91 | 62.15 | 42.67 | |||||
Common Equity, 1 Yr. Growth % | 15.48 | 5.39 | 11.23 | 22.83 | 24.69 | |||||
Cash From Operations, 1 Yr. Growth % | 46.94 | -25.86 | -12.7 | 31.09 | 8.79 | |||||
Capital Expenditures, 1 Yr. Growth % | -54.16 | -34.31 | 4.33 | 26.37 | 21.81 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 138.34 | -28.32 | 10.75 | -86.25 | 769.58 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 121.45 | -27.45 | 18.78 | -73.83 | 352.85 | |||||
Dividend Per Share, 1 Yr. Growth % | 13.33 | 41.18 | 8.33 | 15.38 | -13.33 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -5.4 | 1.2 | 20.69 | 25.55 | 10.61 | |||||
Gross Profit, 2 Yr. CAGR % | -7.4 | 4.3 | 26.04 | 24.8 | 4.86 | |||||
EBITDA, 2 Yr. CAGR % | -7.79 | 22.71 | 31.7 | 26.51 | 3.57 | |||||
EBITA, 2 Yr. CAGR % | -10.93 | 24.33 | 36.89 | 29.9 | 4.49 | |||||
EBIT, 2 Yr. CAGR % | -11.55 | 25.34 | 35.76 | 28.16 | 8.17 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -12.68 | 23.72 | 18.91 | 16 | 12.26 | |||||
Net Income, 2 Yr. CAGR % | -12.81 | 23.49 | 18.91 | 14.34 | 9.4 | |||||
Normalized Net Income, 2 Yr. CAGR % | -12.23 | 21.6 | 23.99 | 17 | 5.85 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -11.66 | 23.54 | 18.86 | 13.93 | 9.01 | |||||
Accounts Receivable, 2 Yr. CAGR % | -5.74 | -4.34 | 22.34 | 28.27 | 8.09 | |||||
Inventory, 2 Yr. CAGR % | -6.98 | 10.94 | 65.76 | 29.46 | 15.03 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 38 | -5.25 | -0.11 | 5.81 | 2.48 | |||||
Total Assets, 2 Yr. CAGR % | 7.48 | 7.02 | 20.73 | 20.95 | 8.4 | |||||
Tangible Book Value, 2 Yr. CAGR % | 9.55 | 14.14 | -23.05 | -6.35 | 52.1 | |||||
Common Equity, 2 Yr. CAGR % | 7.39 | 10.32 | 8.27 | 16.89 | 23.76 | |||||
Cash From Operations, 2 Yr. CAGR % | 52.06 | 4.38 | -19.55 | 6.98 | 19.42 | |||||
Capital Expenditures, 2 Yr. CAGR % | -19.29 | -45.13 | -17.22 | 14.82 | 24.07 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 498.63 | 30.05 | -9.47 | -60.66 | 9.34 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 1.04T | 26.14 | -5.76 | -44.35 | 8.86 | |||||
Dividend Per Share, 2 Yr. CAGR % | 6.46 | 26.49 | 23.67 | 11.8 | 0 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 1.83 | -0.6 | 10.78 | 20.04 | 17.52 | |||||
Gross Profit, 3 Yr. CAGR % | -0.17 | 0.48 | 13.46 | 22.6 | 13.8 | |||||
EBITDA, 3 Yr. CAGR % | 0.57 | 7.06 | 21.87 | 32.19 | 8.71 | |||||
EBITA, 3 Yr. CAGR % | -1.42 | 6.64 | 23.74 | 37.14 | 10.06 | |||||
EBIT, 3 Yr. CAGR % | -1.76 | 6.55 | 23.26 | 36.44 | 11.57 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -3.36 | 3.06 | 14.66 | 24.54 | 7.47 | |||||
Net Income, 3 Yr. CAGR % | -3.54 | 2.96 | 14.52 | 23.35 | 5.64 | |||||
Normalized Net Income, 3 Yr. CAGR % | -4.27 | 4.82 | 15.2 | 26.74 | 4.95 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -2.66 | 3.92 | 14.46 | 23.13 | 5.3 | |||||
Accounts Receivable, 3 Yr. CAGR % | 2.02 | -3.76 | 10.93 | 18.19 | 20.34 | |||||
Inventory, 3 Yr. CAGR % | 6.53 | 15.03 | 24.34 | 43.39 | 27.38 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 28.56 | 21.8 | -1.9 | 2.04 | 3.37 | |||||
Total Assets, 3 Yr. CAGR % | 9.39 | 7.17 | 16.14 | 15.95 | 17.14 | |||||
Tangible Book Value, 3 Yr. CAGR % | 6.78 | 9.52 | -11.01 | -1.34 | 7.76 | |||||
Common Equity, 3 Yr. CAGR % | 8.06 | 6.72 | 10.62 | 12.92 | 19.43 | |||||
Cash From Operations, 3 Yr. CAGR % | 42.41 | 19.68 | -1.66 | -5.33 | 7.58 | |||||
Capital Expenditures, 3 Yr. CAGR % | -12.57 | -24.64 | -32.02 | -4.68 | 17.1 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 150.26 | 194.07 | 24.58 | -51.44 | 10.4 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 129.83 | 353.38 | 24.89 | -38.59 | 11.93 | |||||
Dividend Per Share, 3 Yr. CAGR % | 9.35 | 16.96 | 20.12 | 20.84 | 2.7 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 5.96 | 4.81 | 8.99 | 9.13 | 10.7 | |||||
Gross Profit, 5 Yr. CAGR % | 5.35 | 5.83 | 9.59 | 9.58 | 9.9 | |||||
EBITDA, 5 Yr. CAGR % | 6.09 | 10.52 | 12.03 | 14.45 | 14.11 | |||||
EBITA, 5 Yr. CAGR % | 5.16 | 10.5 | 12.41 | 15.4 | 15.56 | |||||
EBIT, 5 Yr. CAGR % | 4.63 | 10.56 | 11.81 | 14.72 | 16.89 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 2.59 | 8.99 | 5 | 8.05 | 13.7 | |||||
Net Income, 5 Yr. CAGR % | 2.25 | 8.72 | 4.88 | 7.37 | 12.45 | |||||
Normalized Net Income, 5 Yr. CAGR % | 1.78 | 8.62 | 6.28 | 9.53 | 11.32 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 2.73 | 9.26 | 5.43 | 7.82 | 12.25 | |||||
Accounts Receivable, 5 Yr. CAGR % | 5.72 | 4.4 | 9.71 | 7.96 | 9.79 | |||||
Inventory, 5 Yr. CAGR % | 10.13 | 24.44 | 27.14 | 20.6 | 20.53 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 19.1 | 17.36 | 16.22 | 15.14 | -0.17 | |||||
Total Assets, 5 Yr. CAGR % | 10.47 | 8.83 | 13.79 | 12.48 | 12.98 | |||||
Tangible Book Value, 5 Yr. CAGR % | 8.81 | 8.22 | -6.33 | 2.88 | 10.27 | |||||
Common Equity, 5 Yr. CAGR % | 10.07 | 8.04 | 8.14 | 10.68 | 15.7 | |||||
Cash From Operations, 5 Yr. CAGR % | 25.22 | 8.61 | 13.33 | 14.43 | 6.28 | |||||
Capital Expenditures, 5 Yr. CAGR % | -5.15 | -9.74 | -14.46 | -10.82 | -13.53 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 48.19 | 7.05 | 66.29 | 32.36 | 18.63 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 45.99 | 7.54 | 60.58 | 97.09 | 18.12 | |||||
Dividend Per Share, 5 Yr. CAGR % | 19.42 | 24.57 | 14.87 | 14.87 | 11.63 |
- Stock Market
- Equities
- CYIENT Stock
- Financials Cyient Limited
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















